StockClub

AMLX

AMLXAmylyx Pharmaceuticals, Inc.$ --
Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.

AMLX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-44M USD
YoY -15.8%
Net Income
-41M USD
YoY -15.0%
EPS
-0.37$
YoY +11.9%

Revenue

$0
FY2024 Q2$87.6M
$87.6M
Q2
FY2024 Q3$88M
$88M
Q3
FY2024 Q4$87.4M
$87.4M
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-41.3M
FY2024 Q2$-191.5M
$-191.5M
Q2
FY2024 Q3$-264.2M
$-264.2M
Q3
FY2024 Q4$-301.7M
$-301.7M
Q4
FY2025 Q1$-35.9M
$-35.9M
Q1
FY2025 Q2$-77.3M
$-77.3M
Q2
FY2025 Q3$-111.7M
$-111.7M
Q3
FY2025 Q4$-144.7M
$-144.7M
Q4
FY2026 Q1$-41.3M
$-41.3M
Q1
Actual
$-5.4M (-15.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$650,000
FY2020
$650,000
FY2021MISS
Actual:$0
Est:$528,333
FY2021MISS
$0
FY2022BEAT
Actual:$22.2M
Est:$4.4M
FY2022BEAT
$22.2M
FY2023MISS
Actual:$380.8M
Est:$398M
FY2023MISS
$380.8M
FY2024MISS
Actual:$87.4M
Est:$88M
FY2024MISS
$87.4M
FY2025MISS
Actual:$0
Est:$114.5M
FY2025MISS
$0

Analyst Estimates